Renaissance Technologies - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$96
-92.3%
30,282
-88.0%
0.00%
-100.0%
Q2 2023$1,252
-40.9%
251,900
-41.2%
0.00%
-33.3%
Q1 2023$2,118
-23.5%
428,700
-2.6%
0.00%
-25.0%
Q4 2022$2,768
-100.0%
440,100
-54.8%
0.00%
-60.0%
Q1 2022$8,880,000
-51.7%
974,700
+38.4%
0.01%
-56.5%
Q2 2021$18,371,000
+480.6%
704,400
+739.6%
0.02%
+666.7%
Q3 2020$3,164,000
+193.2%
83,900
+232.9%
0.00%
+200.0%
Q2 2020$1,079,00025,2000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders